CD14 (C-159→T) polymorphism and levels of C-reactive protein;CD14 (C-159→T) polymorfizmus a hladina C-reaktivního proteinu

Casopis Lekaru Ceskych

Volumn 142, Issue 3, 2003, Pages 174-176

  Hubáček, Jaroslav A ^a,b   Stavek P ^a,b   Pit'Ha, J ^a,b   Skodova Z ^a   Poledne, R ^a,b  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b Centrum Vyzkumu Chorob Srdce a Cev   (Czech Republic)

Author keywords

C reactive protein; CD14 receptor; Polymorphism

Indexed keywords

C REACTIVE PROTEIN; CD14 ANTIGEN; CYTOSINE; THYMINE;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; DNA POLYMORPHISM; GENETIC MARKER; HOMOZYGOTE; HOST RESISTANCE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; POLYMERASE CHAIN REACTION; RESTRICTION MAPPING; RISK FACTOR; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED;

ADULT; ANTIGENS, CD14; C-REACTIVE PROTEIN; GENE FREQUENCY; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 0037246329     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Chenillot, O., Henny, J., Steinmetz, J. et al.: High sensitivity C-reactive protein: biological variations and reference limits. Clin. Chem. Lab. Med., 38, 2000, s. 1003-1011.
2. Lagrand, W. K., Visser, C. A., Hermes, W. T. et al.: C-reactive protein as a cardiovascular risk factor. More than an epiphenomenona? Circulation, 100, 1999, s. 96-102.
3. Mattila, K. J., Valtonen, V. V., Nieminen, M. S., Asikainen, S.: Role of infection as a risk factor for atherosclerosis, myocardial infarction and stroke. Clin. Infect. Dis., 26, 1998, s. 719-734.
4. Wong, Y. K., Gallagher, P. J., Ward, M. E.: Chlamydia pneumoniae and atherosclerosis. Heart, 81, 1999, s. 232-238.
5. Becker, A. E., de Boer, O. J., van der Wal, A. C.: The role of inflammation and infection in coronary artery disease. Annu. Rev. Med., 52, 2001, s. 289-297.
6. Hubáček, J. A., Poledne, R.: Infekce a ateroskleróza. Prakt. Lék., 80, 2000, s. 246-249.
7. Antal-Szalmás, P.: Evaluation of CD14 in host defence. Eur. J. Clin. Invest., 30, 2000, s. 167-179.
8. Ferrero, E., Hsieh, C. L., Francke, U., Goyert, S. M.: CD14 is a member of the family of leucine-rich proteins and is encoded by a gene syntenic with multiple receptor genes. J. Immunol., 145, 1990, s. 331 až 336.
9. Hubacek, J. A., Poledne, R.: The common cDNA and amino acid sequences of the CD14 receptor (myeloid cell-specific leucine-rich glycoprotein). Physiol. Res., 48, 1999, s. 323-326.
10. Meisel, S. R., Shapiro, H., Radnay, J. et al.: Increased expression of neutrophil and monocyte adhesion molecules LFA-1 and Mac-1 and their ligand ICAM-1 and VLA-4 throughout the acute phase of myocardial infarction. J. Am. Coll. Cardiol., 31, 1998, s. 120-125.
11. LeVan, T. D., Bloom, J. W., Bailey, T. J. et al.: A common single nucleotide polymorphism in the CD 14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J. Immunol., 167, 2001.
12. Hubacek, J. A., Rothe, G., Pitha, J. et al.: C(-260)→T polymorphism in the promoter of the CD14 receptor gene as a new genetic risk factor for myocardial infarction. Circulation, 99, 1999, s. 3218-3220.
13. Baldini, M., Lohman, I. C., Halonen, M. et al.: A polymorphism in the 5* flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am. J. Respir. Cell. Mol. Biol., 20, 1999, s. 976-983.
14. Unkelbach, K., Gardemann, A., Kostrzewa, M. et al.: A new polymorphis in the gene of lipopolysaccharide receptor CD 14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile. Arterioscler. Thromb. Vasc. Biol., 19, 1999, s. 932-938.
15. Shimada, K., Watanabe, Y., Mokuno, M. et al.: Common polymorphism in the promoter of the CD14 receptor gene is associated with acute myocardial infarction in Japanese men. Am. J. Cardiol., 86, 2000, s. 622-624.
16. Zee, R. Y., Lindpaitner, K., Struk, B. et al.: A prospective evaluation of the C(-260)T gene polymorphism and the risk of myocardial infarction. Arteriosclerosis, 154, 2001, s. 699-702.
17. Ito, D., Murata, M., Tanahashi, N. et al.: Polymorphism of promoter of lipopolysaccharide receptor CD14 and ischemic cerebrovascular disease. Stroke, 31, 2000, s. 2661-2664.
18. Miller, S. A., Dykes, D. D., Polesky, H. F.: A simple salting out procedure for extraction DNA from human nucleated cells. Nucleic Acid Res., 16, 1988, s. 1215.